Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

BMC Cancer

Topics

Biology

Biochemistry

Chemistry

Medicine

Cancer Oncology

Show all topics

DOI

10.1186/s12885-024-12505-1

License

CC-BY

Other Formats

PDF